Literature DB >> 307055

Increasing incidence of ampicillin resistance in Hemophilus influenzae.

V Syriopoulou, D Scheifele, A L Smith, P M Perry, V Howie.   

Abstract

The incidence of ampicillin resistance in Hemophilus influenzae and its medical significance have not been extensively determined. During 1975-1977, we tested for ampicillin resistance 489 consecutive middle-ear isolates of HI obtained from children in Huntsville, Alabama, and 719 consecutive laboratory isolates of HI from Children's Hospital, Boston. The annual incidence of Amp resistance rose progressively in each survey, from initial values of 1.4 to 5.3% in 1975, to 14 to 16% in 1977 (P less than 0.05), a mean annual rate of increase approximately twofold. Resistance was equally prevalent among type b and non-b isolates and among nasally carried and disease-associated isolates (from blood, CSF, middle ears). Patients harboring AmpR isolates were much more likely to have had recent exposure to beta-lactam antibiotics (P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307055     DOI: 10.1016/s0022-3476(78)80354-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands.

Authors:  Zaini Mohd-Zain; Sarah L Turner; Ana M Cerdeño-Tárraga; Andrew K Lilley; Thomas J Inzana; A Jane Duncan; Rosalind M Harding; Derek W Hood; Timothy E Peto; Derrick W Crook
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

2.  Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

Authors:  K Tunér; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 3.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Mixed infections with Hemophilus influenzae type b.

Authors:  G Delage; C Gaudreau
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

5.  Ampicillin-resistant Hemophilus influenzae in Canada: nationwide survey of hospital laboratories.

Authors:  D W Scheifele
Journal:  Can Med Assoc J       Date:  1979-07-21       Impact factor: 8.262

6.  Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates.

Authors:  T R Parr; C H Pai; L E Bryan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

7.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  Serotype and ampicillin susceptibility of Haemophilus influenzae causing systemic infections in children: 3 years of experience.

Authors:  E O Mason; S L Kaplan; L B Lamberth; D B Hinds; S J Kvernland; E M Loiselle; R D Feigin
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

Review 9.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

10.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.